Skip to main content


Fig. 6 | Journal of Neuroinflammation

Fig. 6

From: Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson’s disease

Fig. 6

Lenalidomide modulates pro-inflammatory and anti-inflammatory cytokine protein levels in mThy1-α-syn tg mice. Additional cytokine levels were analyzed using a proteomic array in the cytosolic fraction of non-tg or mThy1-α-syn tg mice treated with vehicle, lenalidomide, or thalidomide. Significant results are expressed as relative optical density relative to the non-tg vehicle condition. a IP-10/CXCL10. b JE/CCL2. c TIMP-1. d IL-13. Error bars represent ± SEM. #p < 0.05; **, ##p < 0.01; ***, ###p < 0.001

Back to article page